
The company has exclusive marketing and distribution rights for the first 250 million doses of Sputnik V vaccines in the country. This is assuming a base price of around Rs 150 per dose, the price at which the other two vaccines — Serum Institute’s Covishield and Bharat Biotech’s Covaxin — have been procured by government, analysts say.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/32cK5VE
via
IFTTT
0 comments:
Post a Comment